-
Dendreon Pharmaceuticals Establishes Contract Manufacturing Division
contractpharma
June 16, 2021
Now offers end-to-end manufacturing of complex cell therapies and patient logistics for partner programs.
-
Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction
firstwordpharma
June 15, 2021
Avalon GloboCare Corp. (NASDAQ: AVCO) , a clinical-stage global developer of cell-based technologies and therapeutics, today announced that it has entered into a definitive agreement to acquire Hebei Senlang Biotechnology Co. Ltd.
-
Strengthens Investment in Licensed mRNA Technology Platform with $20M Financing
firstwordpharma
May 25, 2021
Brooklyn today announced it has completed a $20M financing to progress the development of the mRNA gene editing and cell therapies technology recently licensed from Factor Biosciences and Novellus Therapeutics.
-
Cellares Raises $82M To Solve The Biggest Hurdles In Cell Therapy Manufacturing
prnasia
May 08, 2021
Cellares Corporation, a life sciences technology company that automates cell therapy manufacturing, announced it has secured $82 million in a Series B round, bringing total funding to date to $100 million.
-
Cellares Expands Cell Therapy Manufacturing Capabilities
contractpharma
May 06, 2021
Cellares Corporation, a life sciences technology company that automates cell therapy manufacturing, has secured $82 million in a Series B round, bringing total funding to date to $100 million.
-
Bristol Myers Squibb Invests in Cell Therapy Ops
contractpharma
April 28, 2021
Bristol Myers Squibb has selected Leiden, Netherlands to house a new cell therapy manufacturing site in Europe, leveraging the growing life sciences region near Amsterdam and convenient access to transportation for shipping patient cells.
-
BMS to invest in new cell therapy manufacturing site in Europe
pharmatimes
April 26, 2021
Bristol Myers Squibb (BMS) is planning to invest in a new cell therapy manufacturing site based in Leiden in the Netherlands.
-
BMS Expands Cell Therapy Manufacturing Capabilities
contractpharma
March 02, 2021
New state-of-the-art cell therapy manufacturing facility under construction to expand global footprint.
-
G-CON Manufacturing Delivers & Installs PODs for Cell Therapy Manufacturing
contractpharma
February 20, 2021
G-CON Manufacturing, a leader in prefabricated, flexible cleanroom solutions, has successfully delivered and installed three PODs to a clinical-stage immuno-oncology company for cell therapy manufacturing.
-
Catalent, Trizell Enter Cell Therapy Deal
contractpharma
February 09, 2021
Catalent has signed an agreement with Trizell GmbH, to support the manufacturing of Trizell’s Phase 1 cell therapy for the treatment of micro- and macroangiopathies.